Research
JAMA | OriginalInvestigation
EffectofIncisionalNegativePressureWoundTherapyvsStandard
WoundDressingonDeepSurgicalSiteInfectionAfterSurgery
forLowerLimbFracturesAssociatedWithMajorTrauma
TheWHISTRandomizedClinicalTrial
MatthewL.Costa,PhD;JuulAchten,PhD;RuthKnight,PhD;JulieBruce,PhD;SusanJ.Dutton,MSc;JasonMadan,PhD;MelinaDritsaki,PhD;
NickParsons,PhD;MiguelFernandez,PhD;RichardGrant;JagdeepNanchahal,PhD;fortheWHISTTrialCollaborators
VisualAbstract
IMPORTANCEFollowingsurgerytotreatmajortrauma–relatedfractures,deepwound
Editorialpage513
infectionratesarehigh.Itisnotknownifnegativepressurewoundtherapycanreduce
infectionratesinthissetting. Supplementalcontent
CMEQuizat
OBJECTIVEToassessoutcomesinpatientswhohaveincisionsresultingfromsurgeryfor
jamanetwork.com/learning
lowerlimbfracturesrelatedtomajortraumaandweretreatedwitheitherincisionalnegative
pressurewoundtherapyorstandardwounddressing.
DESIGN,SETTING,ANDPARTICIPANTSArandomizedclinicaltrialconductedat24trauma
hospitalsrepresentingtheUKMajorTraumaNetworkthatincluded1548patientsaged16
yearsorolderwhounderwentsurgeryforalowerlimbfracturecausedbymajortraumafrom
July7,2016,throughApril17,2018,withfollow-uptoDecember11,2018.
INTERVENTIONSIncisionalnegativepressurewoundtherapy(n=785),whichinvolveda
specializeddressingusedtocreatenegativepressureoverthewound,vsstandardwound
dressingnotinvolvingnegativepressure(n=763).
MAINOUTCOMESANDMEASURESTheprimaryoutcomemeasurewasdeepsurgicalsite
infectionat30daysdiagnosedaccordingtothecriteriafromtheUSCentersforDiseaseControl
andPrevention.Apreplannedsecondaryanalysisoftheprimaryoutcomewasperformed
at90days.Thesecondaryoutcomeswerepatient-reporteddisability(DisabilityRatingIndex),
health-relatedqualityoflife(EuroQol5-levelEQ-5D),surgicalscarassessment(Patientand
ObserverScarAssessmentScale),andchronicpain(DouleurNeuropathiqueQuestionnaire)
at3and6months,aswellasotherlocalwoundhealingcomplicationsat30days.
RESULTSAmong1548participantswhowererandomized(mean[SD]age,49.8[20.3]years;
561[36%]wereaged(cid:2)40years;583[38%]women;and881[57%]hadmultipleinjuries),
1519(98%)haddataavailablefortheprimaryoutcome.At30days,deepsurgicalsite
AuthorAffiliations:OxfordTrauma,
infectionoccurredin5.84%(45of770patients)oftheincisionalnegativepressurewound NuffieldDepartmentof
therapygroupandin6.68%(50of749patients)ofthestandardwounddressinggroup Orthopaedics,Rheumatology,and
MusculoskeletalSciences,University
(oddsratio,0.87[95%CI,0.57to1.33];absoluteriskdifference,−0.77%[95%CI,−3.19%to
ofOxford,Oxford,England(Costa,
1.66%];P=.52).Therewasnosignificantdifferenceinthedeepsurgicalsiteinfectionrateat Achten,Fernandez,Nanchahal);
90days(11.4%[72of629patients]intheincisionalnegativepressurewoundtherapygroup OxfordClinicalTrialsResearchUnit,
vs13.2%[78of590patients]inthestandardwounddressinggroup;oddsratio,0.84[95% NuffieldDepartmentof
Orthopaedics,Rheumatology,and
CI,0.59to1.19];absoluteriskdifference,−1.76%[95%CI,−5.41%to1.90%];P=.32).
MusculoskeletalSciences,University
Forthe5prespecifiedsecondaryoutcomesreported,therewerenosignificantdifferences ofOxford,Oxford,England(Knight,
atanytimepoint. Dutton,Dritsaki);ClinicalTrialsUnit,
WarwickMedicalSchool,University
CONCLUSIONSANDRELEVANCEAmongpatientswhounderwentsurgeryformajor ofWarwick,Coventry,England
trauma–relatedlowerlimbfractures,useofincisionalnegativepressurewoundtherapy, (Bruce,Madan);Statisticsand
EpidemiologyUnit,WarwickMedical
comparedwithstandardwounddressing,resultedinnosignificantdifferenceintherateof
School,UniversityofWarwick,
deepsurgicalsiteinfection.Thefindingsdonotsupporttheuseofincisionalnegative Coventry,England(Parsons);
pressurewoundtherapyinthissetting,althoughtheeventrateat30dayswas Nuneaton,England(Grant).
lowerthanexpected. GroupInformation:TheWHISTTrial
Collaboratorsappearattheendof
TRIALREGISTRATIONisrctn.orgIdentifier:ISRCTN12702354 thearticle.
CorrespondingAuthor:MatthewL.
Costa,PhD,UniversityofOxford,
JAMA.2020;323(6):519-526.doi:10.1001/jama.2020.0059 OxfordOX39DU,England(matthew.
CorrectedonJuly20,2021. costa@ndorms.ox.ac.uk).
(Reprinted) 519
©2020AmericanMedicalAssociation.Allrightsreserved.
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
Research OriginalInvestigation EffectofIncisionalNegativePressureWoundTherapyvsStandardWoundDressingonDeepSSI
I
n2010,traumawastheleadingcauseofdeathworldwide
amongthoseyoungerthan45years.1Majortrauma,de- KeyPoints
finedaswhenmorethan1bodysystemisinjuredoraniso-
Question Amongpatientsundergoingsurgeryforlowerlimb
latedlimbhasbeensubjectedtoseveretrauma,isasignifi- fracturesrelatedtomajortrauma,isthereadifferenceindeep
cantcauseofshort-andlong-termmorbidityandakeycost surgicalinfectionrateswhenthewoundistreatedwithincisional
driverinbothacutehealthcareandsubsequentsocialcare.2 negativepressurewoundtherapyvsstandardwounddressing?
Eighty-fivepercentofpatientswithmajortraumasustainse-
Findings Inthisrandomizedclinicaltrialthatincluded1548adults,
riouslimbinjuries,mostcommonlyfracturedbones.3Treat-
therewasnostatisticallysignificantdifferenceintherateofdeep
ingthesefracturesiscomplicatedbythesystematicinflam- surgicalsiteinfectionat30daysbetweenincisionalnegativepressure
matoryresponsetomajortrauma,aswellastheextensivesoft woundtherapy(5.8%)andstandardwounddressing(6.7%).
tissueinjuriesadjacenttothebrokenbonewhich,takento-
Meaning Thefindingsdonotsupporttheuseofincisional
gether,maycausehighratesofwoundinfectionfollowing negativepressurewoundtherapyforsurgicalwoundsassociated
surgeryforlowerlimbfracturesaftermajortrauma.4,5 withlowerlimbfracturesfrommajortrauma,althoughtheevent
Oneofthefactorsthatmayreducetheriskofinfectionin rateat30dayswaslowerthanexpected.
thesurgicalwoundsofpatientswithmajortraumaisthetype
ofdressingappliedovertheincisionattheendoftheopera-
tion.Newtechniquesforwoundmanagement,suchasinci-
sionalnegativepressurewoundtherapy,haveshownpromis- Patientswereexcludediftheywereunabletoadheretothe
ingresultsfollowingsometypesofsurgeryandthesetechniques trialproceduresorcompletequestionnaires(eg,hadapreex-
havethepotentialforreducingwoundinfections;however,there istingdiagnosisofdementiaoranopenfractureandthewound
islimitedevidenceamongpatientswithwoundsassociatedwith couldnotbeclosedafterthefirstsurgery).Patientswithopen
surgeryforlowerlimbfracturescausedbymajortrauma.6,7 fracturesthatcannotbeclosedatthefirstsurgeryareatthehigh-
Theaimofthisrandomizedclinicaltrialwastodetermine estriskofsurgicalsiteinfection.Incisionalnegativepressure
ifincisionalnegativepressurewoundtherapywasmoreeffec- woundtherapycannotbeappliedtothesetypesofwounds.
tivethanstandardwounddressinginreducingtherateofdeep
surgicalsiteinfectioninwoundsassociatedwithsurgeryfora RandomizationandMasking
fractureinthecontextofmajortraumatothelowerlimb. Acomputer-generatedrandomizationalgorithmwascreated
anddeliveredbyanaccreditedclinicaltrialsunittoensurethe
allocationsequencewasconcealed.Eachpatientwasrandom-
izedtotreatmentona1:1basis,stratifiedbytrialrecruitment
Methods
center,InjurySeverityScore(ISS)of15orlessvsISSof16or
TheNationalResearchEthicsServiceapprovedthestudy.The greater(ISSwasusedasasurrogateforthedegreeofsystemic
trialprotocolappearsinSupplement1andthestatisticalanaly- inflammatoryresponseassociatedwiththeinjuries)andopen
sisplanappearsinSupplement2andwerebothpublished8,9; orclosedfractureatpresentation(onlythoseopenfractures
modificationstotheprotocolappearinSupplement3.Thetrial forwhichthewoundcouldbeclosedprimarilyafterthefirst
wasoverseenbyindependentsteeringanddataandsafety surgicalwounddebridementwereeligibleforinclusionbe-
monitoringcommittees.Eligiblepatientswereapproachedby causeincisionalnegativepressurewoundtherapycannotbe
alocalresearcherandwereprovidedwithverbalandwritten appliedtowoundsthatareleftopen).Aprobabilisticelement
informationaboutthetrialbeforebeingaskedtoprovidewrit- wasincludedintheminimizationalgorithmtoensureunpre-
teninformedconsent. dictabilityoftreatmentassignment.Whenapatiententered
Forpatientswithacuteconfusionalstatesortemporaryim- thetrial,nonidentifiabledetailswereloggedonthesecure,en-
pairmentofconsciousness,weapproacheda“consultee”topro- crypted,web-basedsystem.
videagreementonbehalfofthepatientaspertheUKMental Participantswereassignedtreatmentintraoperativelyatthe
CapacityAct2005.Allparticipantsrandomizedunderthispro- endofsurgeryonceitwasdeterminedthatthesurgicalwound
visionweresubsequentlyapproachedforwrittenconsentonce couldbeclosedbutbeforeanywounddressingwasapplied
capacitywasrestored,withtheoptiontocontinueordiscon- (Figure).Itwasnotpossibletoblindtrialparticipantstotreat-
tinueinvolvementinthetrial.Forthisreason,higherlevelsof mentbecausethewounddressingwasclearlyvisible.Inaddi-
postrandomizationwithdrawalwereanticipatedthanmightbe tion,thetreatingsurgeonscouldnotbeblindedtotheinter-
expectedinmostclinicaltrials. vention;however,thesurgicalandhealthcareteamswerenot
Thetrialtookplaceat24majortraumahospitalsrepresent- involvedinanytrialassessmentsandtheprimaryoutcomedata
ingtheUKMajorTraumaNetwork.IntheUnitedKingdom, werecollectedbyindependentresearchassociates.
patientswithmajortraumaaretransporteddirectlytoaspe-
cialisttraumacenter.Eligiblepatientswereaged16yearsor Interventions
olderwithalowerextremityfracturecausedbymajortrauma Allpatientsreceivedageneralorregionalanesthetic.Theop-
thatrequiredsurgeryand,postoperatively,hadawoundthat erativetreatmentfollowedstandardclinicalpracticewithrel-
couldbeclosed.Patientshadtopresenttothetrialhospital evantdetailsrecordedbytheresearchteam.Attheendofthe
within72hoursoftheirinjury,includingthosewhoweretrans- operation,adressingwasappliedtothesurgicalwound.The
ferredfromotherhospitals. patientwasrandomizedtoincisionalnegativepressurewound
520 JAMA February11,2020 Volume323,Number6 (Reprinted) jama.com
©2020AmericanMedicalAssociation.Allrightsreserved.
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
EffectofIncisionalNegativePressureWoundTherapyvsStandardWoundDressingonDeepSSI OriginalInvestigation Research
therapyorstandardwounddressing.Allotherelementsofpost-
Figure.PatientRecruitment,Randomization,andFollow-up
operativecareremainedthesame.Thewoundcouldbere-
intheWHISTStudy
dressedagainonthewardatthediscretionoftheclinicalteam;
anyfurtherwounddressingwasrecordedandfollowedtheran-
2065Patients eligible to participate
domizedtreatmentunlessotherwiseclinicallyindicated.
436Excluded
IncisionalNegativePressureWoundTherapyGroup 274Refused to participate
162Surgeon preference
Incisionalnegativepressurewoundtherapyusesasiliconecon-
tactlayerwithasilicon-basedadhesive,anairlocklayer,asu-
perabsorbentlayer,andapolyurethane(semipermeable)layer 1629Randomized
onthetopthatmakesthesystemwaterproofwhileallowing
watervaportopass.Asealedtubeconnectsthedressingtoa 813Randomized to receive incisional 816Randomized to receive standard
built-inmini-pumpthatcreatesapartialvacuum(−80mmHg negative pressure wound therapy wound dressing
ofnegativepressure)overthewound.Incisionalnegativepres-
surewoundtherapywasappliedtothewoundattheendof
28Excluded 53Excluded
20Refused to participate 38Refused to participate
theoperationasperthetreatingsurgeon’snormalpracticeand 5Not eligible to participate 14Not eligible to participate
accordingtothedressingmanufacturer’sinstructions. 3Randomized in error 1Randomized in error
785Provided consent to participate 763Provided consent to participate
StandardWoundDressingGroup 693Received negative pressure 755Received standard wound
Allcentersusedasteriledressingobtainedfromsealedpackages wound therapy as randomized dressing as randomized
92Did not receive intervention 8Did not receive intervention
thatpreventedexternalcontamination.However,theprecisede-
as randomized as randomized
tailsofthematerialsusedwerelefttothediscretionofthetreat-
inghealthcareteamasperroutinecareattheircenter.Details 781Had baseline response 759Had baseline response
ofeachdressingappliedinthetrialwererecordedandclassified 4Did not have baseline response 4Did not have baseline response
2Withdrew from study 2Withdrew from study
accordingtoBritishNationalFormularyclassification. 1Died 1Died
1Lost to follow-up 1Lost to follow-up
DataCollectionandOutcomeMeasures
Theprimaryoutcomemeasureforthisstudywasdeepsurgi- 770Included in primary outcome 749Included in primary outcome
analysis at 30 d analysis at 30 d
calsiteinfection.TheUSCentersforDiseaseControlandPre- 15Excluded from primary outcome 14Excluded from primary outcome
vention(CDC)definessurgicalsiteinfectionasa“deepinfec- analysis analysis
5Withdrew from study 5Withdrew from study
tion”involvingthetissuesdeeptotheskinthatoccurswithin 2Died 5Died
30daysofinjury.10Thetreatingclinicalteamrecordedanysigns 8Lost to follow-up 4Lost to follow-up
orsymptomsofwound-relatedinfectioninthemedicalrec-
ordperroutineclinicalpractice.Thetreatingclinicianswere
notpartoftheresearchteam.
Theparticipantswereclinicallyassessed,andthemedi- Therewereseveralsecondaryoutcomesmeasureddur-
calrecordswerereviewedbyanindependentresearchasso- ingthe6monthsafterrandomization:(1)patient-reportedDis-
ciatewhorecordedtheprimaryoutcomeofdeepsurgicalsite abilityRatingIndex(range,0to100points[0,normalfunc-
infectionagainsttheCDCcriteriaforthediagnosisofdeepin- tion;100,completedisability];minimalclinicallyimportant
fection.Thefirstcriterionwaswhetherfluidwasleakingfrom differenceof8points)11;(2)health-relatedqualityoflifeusing
thewoundandwhetherthefluidwaspus.Thesecondcrite- theEuroQol5-levelEQ-5D(range,−0.594to1[0,death;ahigher
rionincludedatleastonedescriptionfromeachofthefollow- scorerelatestobetterqualityoflife])12;(3)self-reportedqual-
ing:(1)thewoundwasgapingopen(dehisced)orasurgeonhad ityofwoundhealingusingthepatientscalefromthePatient
deliberatelyopenedthewoundand(2)theareaaroundthe andObserverScarAssessmentScale(range,1to10[1,normal
woundwaspainfulortenderortheparticipanthadafever skin;10,verydifferentfromnormalskin])13;and(4)patient-
higherthan38°C.Thethirdcriterionwaswhethertherewas reportedDouleurNeuropathiqueQuestionnaireforchronic
anysignofabscessorinfectionondirectexaminationor pain(responsesto7questions;neuropathicpainconsidered
imaging(eg,ultrasound). presentifansweredyesto≥3questions).14Localwoundcom-
Shortlyafterthestartofthistrial,theCDCupdatedits plicationsotherthandeepsurgicalsiteinfectionwerecol-
criteriaforadeepsurgicalsiteinfectioninpatientstreatedfor lectedupto30days.Resourceusedatawerecollectedbutare
fracturefixation.Specifically,theendpointforwoundsinvolv- notreportedherein.
inganimplantwaschangedfrom30daysto90days.Because
infectionat90dayswascapturedundertheoutcomemeasure StatisticalAnalysis
forwoundcomplications,nochangesweremadetodatacollec- Intheonlypriorrandomizedclinicaltrial7thatcomparedin-
tion.However,tofacilitatefutureevidencesynthesis,andafter cisionalnegativepressurewoundtherapyvsstandardwound
consultationwiththetrialsteeringcommittee,weincludedasec- dressingforsurgicalincisionsassociatedwithmajortrauma
ondaryanalysisoftheprimaryoutcomeofdeepsurgicalsite tothelowerlimb,therateoflate(deep)infectionwasre-
infectionat90dayswithinthestatisticalanalysisplan. ducedby6%intheincisionalnegativepressurewoundtherapy
jama.com (Reprinted) JAMA February11,2020 Volume323,Number6 521
©2020AmericanMedicalAssociation.Allrightsreserved.
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
Research OriginalInvestigation EffectofIncisionalNegativePressureWoundTherapyvsStandardWoundDressingonDeepSSI
group.Intheabsenceofacommonlyacceptedminimumclini- capacitytoparticipateinthestudypriortosurgeryorwere
callyimportantdifferencefordeepwoundinfection,sur- unableorunwillingtoprovideinformedconsentafterran-
geonsintheUKOrthopaedicTraumaSocietywhoperformsur- domization.Amongtheremaining1548participants(mean
geryformajortraumaweresurveyedtodeterminewhatthey [SD]age,49.8[20.3]years;561[36%]wereaged≤40years;
believedwasaclinicallyimportantreductionindeepsurgical 583[38%]women;964[62%]men;and881[57%]hadmul-
siteinfectionrates.Thesurvey(basedon120respondents) tipleinjuries),1519(98%)haddataavailablefortheprimary
showedthata6%reductionintherateof“deepinfection” outcome(Figure).Datasumto1547formenandwomen
wouldbesufficienttochangeclinicalpracticewithregardto becausewewereunabletoreportsexfor1personwhowith-
thechoiceofwounddressing. drewimmediatelyafterrandomization.Themajorityofpar-
Assumingareductionfrom15%(basedonapriorrandom- ticipantshadaclosedfracture(81%)withanISSof15orless
izedclinicaltrial7)to9%intheproportionofpatientshaving (78%).Thecharacteristicsofthe2groupswerewellbalanced
adeepsurgicalsiteinfection,615patientswouldberequired afterrandomization(Table1).
ineachgrouptoprovide90%poweratthe5%level.There- Therewasnosignificantdifferenceintheprimaryout-
fore,weaimedtorecruit1540participantstoaccountforup comemeasureofdeepsurgicalsiteinfectionat30daysbe-
to20%ofpatientsbeinglosttofollow-up. tweenthegroupsasrandomized.Therateofdeepsurgicalsite
Pertheprespecifiedanalysisplan,whichwasapproved infectionat30dayswas5.84%(45/770)intheincisionalnega-
bytheindependentdataandsafetymonitoringcommittee, tivepressurewoundtherapygroupvs6.68%(50/749)inthe
theratesofdeepsurgicalsiteinfectioninthe2groupswere standardwounddressinggroup(OR,0.87[95%CI,0.57to1.33];
comparedusingamixed-effectslogisticregressionmodel. absoluteriskdifference,−0.77%(95%CI,−3.19%to1.66%);
Themodelincludedarandomeffectduetorecruitmentcen- P=.52)(Table2).
ter,andfixedeffectstoadjustforopenvsclosedfracturesat Therewasnosignificantdifferenceinthesecondary
presentation,ISSlevel(≤15vs≥16),participantage,andpar- analysisoftheper-protocolpopulationorinthesensitivity
ticipantsex.Theoddsratio(OR),95%CI,andassociated analysisusingmultipleimputation.Intheper-protocolpopu-
Pvaluewereusedtocomparethe2treatmentgroups;the lation,therateofdeepsurgicalsiteinfectionat30dayswas
absoluteriskdifferencealsowasreported.Thisanalysiswas 6.14%(41/668)intheincisionalnegativepressurewound
performedaccordingtotherandomizationgroup(random- therapygroupvs6.57%(48/731)inthestandardwound
izedpopulation). dressinggroup(OR,0.93[95%CI,0.60to1.44];absoluterisk
Asecondaryanalysiswasperformedfortheprimaryout- difference,0.33%[95%CI,−2.93%to2.15%];P=.76).Inthe
comemeasureaccordingtothetypeofdressingactually randomizedpopulation,therewasnosignificantdifference
applied(per-protocolpopulation).Binarysecondaryout- indeepsurgicalsiteinfectionat90days;theratewas11.4%
comemeasureswereanalyzedusingsimilarlogisticregres- (72/629)intheincisionalnegativepressurewoundtherapy
sionmodels.Analogousmultilevel,mixed-effectslinear groupvs13.2%(78/590)inthestandardwounddressing
regressionmodelswereusedforthecontinuoussecondary group(OR,0.84[95%CI,0.59to1.19];absoluteriskdiffer-
outcomemeasures.Themodelsusedrepeatedmeasures ence,−1.76%[95%CI,−5.41%to1.90%];P=.32).
nestedwithinparticipantsandwereadjustedforfixedand Similarly,therewasnosignificantdifferencebetweenthe
randomeffectsasintheprimaryoutcomemodel.Themod- groupsforthesecondaryoutcomemeasures.Themeanscore
elsreliedonassumptionsoflinearity,normalityofresiduals, forparticipants’self-reportedDisabilityRatingIndexat6
homoscedasticity,andwithoutcorrelationbetweenlevel1 monthswas40.6(95%CI,38.3to42.8)intheincisional
andlevel2residuals;theseassumptionswerecheckedvia negativepressurewoundtherapygroupvs40.2(95%CI,37.7
appropriateplots.Allsecondaryanalyseswereperformed to42.8)inthestandardwounddressinggroup(between-
accordingtorandomizationgroup(randomizedpopulation). groupmeandifference,0.03[95%CI,−2.82to2.88];P=.98).
Themainanalysesfortheprimaryandsecondaryout- Themeanscoreforhealth-relatedqualityoflife(EuroQol
comeswereperformedusingavailablecasesonly.Inasensi- 5-levelEQ-5D)at6monthswas0.58(95%CI,0.55to0.60)in
tivityanalysis,multipleimputationforthemissingpri- theincisionalnegativepressurewoundtherapygroupvs
maryoutcomedatawasperformedunderthemissingat 0.58(95%CI,0.55to0.60)inthestandardwounddressing
randomassumption. group(between-groupmeandifference,0[95%CI,−0.03to
A2-sidedsignificancelevelof.05wasusedthroughout. 0.04];P=.86).
BecauseofthepotentialfortypeIerrorduetomultiplecom- Themeanscoreforoverallself-assessmentofthesurgical
parisons,thefindingsforthesecondaryendpointanalyses scarat30dayswas4.35(95%CI,4.15to4.56)intheinci-
shouldbeinterpretedasexploratory.Stataversion15.0 sionalnegativepressurewoundtherapygroupvs4.58(95%
(StataCorp)wasusedforallanalyses. CI,4.37to4.79)inthestandardwounddressinggroup(mean
between-groupdifference,−0.18[95%CI,−0.46to0.10];
P=.22).Theproportionofpatientsreportingchronicneuro-
pathicpain(DouleurNeuropathiqueQuestionnaire)at6
Results
monthswas28.3%intheincisionalnegativepressurewound
Atotalof1629patientswererandomizedbetweenJuly7, therapygroupvs31.9%inthestandardwounddressing
2016,andApril17,2018,withfollow-uptoDecember11, group(OR,0.84[95%CI,0.61to1.15];absoluteriskdiffer-
2018.Eighty-onepatientsdidnothavesufficientmental ence,−3.5%[95%CI,−9.9%to2.8%];P=.27)(Table2).
522 JAMA February11,2020 Volume323,Number6 (Reprinted) jama.com
©2020AmericanMedicalAssociation.Allrightsreserved.
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
EffectofIncisionalNegativePressureWoundTherapyvsStandardWoundDressingonDeepSSI OriginalInvestigation Research
Table1.BaselineCharacteristicsofParticipants
No./TotalNo.(%)a
IncisionalNegativePressure StandardWound
WoundTherapy Dressing
Sex
Male 482/784(61.5) 482/763(63.2)
Female 302/784(38.5) 281/763(36.8)
Age≤40y 283/784(36.1) 278/763(36.4)
Race/ethnicity
White 701/773(90.7) 667/741(90.0)
BlackCaribbean 9/773(1.2) 6/741(0.8)
BlackAfrican 15/773(1.9) 13/741(1.8)
Otherblack 2/773(0.3) 4/741(0.5)
Indian 7/773(0.9) 11/741(1.5)
Pakistani 7/773(0.9) 14/741(1.9)
Bangladeshi 1/773(0.1) 3/741(0.4)
Chinese 0/773 1/741(0.1)
Otherb 31/773(4.0) 22/741(3.0)
Bodymassindex, 26.4(5.9) 26.7(6.0)
mean(SD)c
Mechanismofinjury
Roadtrafficcollision 298/780(38.2) 273/759(36.0) aUnlessotherwiseindicated.
Lowenergyfall 275/780(35.3) 252/759(33.2) bIncludesunspecifiedrace/ethnicity.
Highenergyfall 139/780(17.8) 145/759(19.1) cCalculatedasweightinkilograms
Crushinjury 16/780(2.1) 16/759(2.1) dividedbyheightinmeters
squared.
Contactsports 10/780(1.3) 12/759(1.6)
dAunitisequivalentto10mL
Other 42/780(5.4) 61/759(8.0) ofpurealcohol.
Preinjurydiagnosis 63/775(8.1) 85/750(11.3) eAnanatomicalscorethatmeasures
ofdiabetes
theoverallseverityofinjured
Regularsmoker 218/762(28.6) 216/740(29.2) patientsin6bodyregions;range,
Alcoholconsumption 627/756(82.9) 609/730(83.4) 1to75.Injurieswereassignedan
≤14U/wkd AbbreviatedInjuryScalecodeand
InjurySeverityScore≤15e 609/784(77.7) 598/763(78.4) anassociatedscorefrom1(minor
injury)to6(aninjurythatisthought
Woundclosed 637/784(81.3) 622/763(81.5)
tobeincompatiblewithlife).
atpresentation
Patientswithmultipleinjuriesare
Woundabovetheknee 474/781(60.7) 447/759(58.9)
scoredbyaddingtogetherthe
Typeofclosure squaresofthe3highestscores;for
example,52+52+52equals75,
Subcuticularsuture 242/774(31.3) 220/756(29.1)
whichisthemaximumsurvivable
Skinclips 198/774(25.6) 216/756(28.6) score.Byconvention,apatientwith
Interruptedsutures 203/774(26.2) 200/756(26.5) anAbbreviatedInjuryScalecodeof
6in1bodyregionisgivenanInjury
Otherskinclosure 131/774(16.9) 120/756(15.9)
SeverityScoreof75.
OtherwoundhealingcomplicationsnotmeetingtheCDC
criteriafordeepsurgicalsiteinfectionappearinTable3.No Discussion
significantdifferencesbetweenthe2groupswereidentified.
Themostcommoncomplicationwasapainfulortenderwound Thismulticentertrialofpatientsundergoingsurgeryfor
reportedby24.4%ofparticipantsintheincisionalnegative fracturesofthelowerlimbassociatedwithmajortrauma
pressurewoundtherapygroupvs27.6%ofparticipantsinthe foundnosignificantdifferenceintherateofdeepsurgical
standardwounddressinggroup(adjustedOR,0.84[95%CI, siteinfectionat30daysbetweenpatientswhosesurgical
0.65to1.08];absoluteriskdifference,−3.0%[95%CI,−7.4% woundwastreatedwithincisionalnegativepressurewound
to1.4%];P=.18).Onlyasmallnumberofparticipantsre- therapyandthosetreatedwithstandardwounddressing.
ceivedanantibiotictotreatawoundcomplicationthatwasnot Therewasnosignificantdifferenceintherateofdeepsurgi-
adeepsurgicalsiteinfection(3.5%intheincisionalnegative calsiteinfectionat90days.Furthermore,therewasnoevi-
pressurewoundtherapygroupvs3.9%inthestandardwound denceofanysignificantdifferencesinpatientself-reported
dressinggroup;adjustedOR,0.87[95%CI,0.50to1.51];ab- disability,health-relatedqualityoflife,scarhealing,chronic
soluteriskdifference,−0.5%[95%CI,−2.5%to1.5%];P=.61). pain,orotherwoundhealingcomplications.
jama.com (Reprinted) JAMA February11,2020 Volume323,Number6 523
©2020AmericanMedicalAssociation.Allrightsreserved.
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
semoctuOyradnoceSdnayramirPnospuorGtnemtaerTfonosirapmoC.2elbaT
tnemtaerTdetsujdA
dnuoWdradnatS
evitageNlanoisicnI
beulaVP
)IC%59(tceffE
agnisserD
ayparehTdnuoWerusserP
emoctuOyramirP
)%(.oNlatoT/.oN,d03tanoitcefnietislacigruspeeD
25.
)33.1ot75.0(78.0,RO
)86.6(947/05
)48.5(077/54
noitalupopdezimodnaR
67.
)44.1ot06.0(39.0,RO
)75.6(137/84
)41.6(866/14
noitalupoplocotorp-reP
94.
)13.1ot75.0(68.0,RO
)86.6(367/15
)78.5(487/64
noitalupopsisylanayramirP
23.
)91.1ot95.0(48.0,RO
)2.31(095/87
)4.11(926/27
,noitalupopdezimodnarnid09taemoctuoyramirpfosisylanayradnoceS
)%(.oNlatoT/.oN
semoctuOyradnoceSdetropeR-fleS
c)IC%59(naem,xednIgnitaRytilibasiD
99.>
)87.2ot97.2−(10.0−,DM
)654=n(
)705=n(
om3tA
)3.35ot9.84(1.15
)6.35ot5.94(6.15
89.
)88.2ot28.2−(30.0,DM
)234=n(
)964=n(
om6tA
)8.24ot7.73(2.04
)8.24ot3.83(6.04
,D5-QElevel-5loQoruEybdessessaefilfoytilauqdetaler-htlaeH
d)IC%59(naem
48.
)40.0ot30.0−(0,DM
)074=n(
)825=n(
om3tA
)25.0ot74.0(94.0
)25.0ot74.0(05.0
68.
)40.0ot30.0−(0,DM
)644=n(
)684=n(
om6tA
)06.0ot55.0(85.0
)06.0ot55.0(85.0
e)IC%59(naem,D5-QElevel-5loQoruEnoelacsgolanalausiV
85.
)48.1ot03.3−(37.0−,DM
)874=n(
)135=n(
om3tA
)8.66ot7.26(7.46
)0.66ot2.26(1.46
59.
)47.2ot75.2−(80.0,DM
)944=n(
)984=n(
om6tA
)5.17ot4.76(4.96
)5.17ot8.76(7.96
f)IC%59(naem,erocstnemssessaracS
22.
)01.0ot64.0−(81.0−,DM
)616=n(
)756=n(
d03tA
)97.4ot73.4(85.4
)65.4ot51.4(53.4
15.
)02.0ot14.0−(11.0−,DM
)074=n(
)325=n(
om3tA
)11.5ot16.4(68.4
)59.4ot74.4(17.4
25.
)24.0ot12.0−(11.0,DM
)734=n(
)384=n(
om6tA
)77.4ot72.4(25.4
)68.4ot63.4(16.4
,eriannoitseuQeuqihtaporueNrueluoDybdessessaniapcihtaporuencinorhC
g)%(.oNlatoT/.oN
27.
)13.1ot86.0(49.0,RO
)2.23(933/901
)2.13(263/311
om3tA
72.
)51.1ot16.0(48.0,RO
)9.13(763/711
)3.82(414/711
om6tA
ytilituetubirttaitlumotdetrevnocerewserocS.efilfoytilauqrettebetacidniserocsrehgih;1ot495.0−,egnaRd
.oitarsddo,RO;ecnereffidnaem,DM:snoitaiverbbA
.steseulavL3-D5-QEdnaklawssorcehtgnisuseulav
enilesab,etairporppanehw,dna,xes,egatnapicitrap,erocSytireveSyrujnI,sdnuowdesolcsvneporofdetsujdAa
.efilfoytilauqrettebetacidniserocsrehgih;001ot0,egnaRe
sa)D5-QElevel-5loQoruEnoelacsgolanalausivdnaefilfoytilauqdetaler-htlaeh;xednIgnitaRytilibasiD(serocs
.nikslamronmorftnereffidyrev,01;nikslamronsetacidni1;01ot1,egnaRf
sawnoitatupmielpitlum,sisylanaytivitisnesasA.tceffemodnarasaretnecgnizimodnarrofdna,stceffedexif
.noitpmussamodnartagnissimehtrednuatademoctuoyramirpgnissimrofdesu
niaptuobasnoitseuq7ehtfoeromro3otseydednopsertnapicitrapafI.niapcihtaporuenfoerusaemyraniBg
dezimodnarehtrofelbaliavaerewataD.tneserpebotderedisnocsawniapcihtaporuen,scitsiretcarahc
serusaem-detaepermorfdnaselbairavyranibrofsledomnoissergercitsigolstceffe-deximmorfdetaluclaCb
.noitalupop
.selbairavsuounitnocrofsledomnoissergerraenilstceffe-dexim
snoitseuq21llassorcanaemasadetaluclacerewserocS.ytilibasidsseletacidniserocsrehgih;001ot0,egnaRc
.snoitseuq01tsaeltaderewsnaohwstnapicitraprofdetupmierewdna
Research OriginalInvestigation EffectofIncisionalNegativePressureWoundTherapyvsStandardWoundDressingonDeepSSI
524 JAMA February11,2020 Volume323,Number6 (Reprinted) jama.com
©2020AmericanMedicalAssociation.Allrightsreserved.
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
EffectofIncisionalNegativePressureWoundTherapyvsStandardWoundDressingonDeepSSI OriginalInvestigation Research
Table3.OtherWoundComplicationsatorPriorto30Days
No./TotalNo.(%)
IncisionalNegativePressure StandardWound AbsoluteRiskDifference AdjustedOddsRatio
WoundTherapy(n=739) Dressing(n=713) (95%CI),% (95%CI) PValue
Woundhealingcomplicationa
Redandinflamed 76/715(10.6) 90/684(13.2) −2.7(−6.0to6.5) 0.76(0.55to1.07) .11
Swollen 147/715(20.6) 137/684(20.0) 0.5(−3.5to4.6) 1.03(0.79to1.36) .81
Painfulortender 173/710(24.4) 188/682(27.6) −3.0(−7.4to1.4) 0.84(0.65to1.08) .18
Fever>38°C 61/713(8.6) 67/681(9.8) −1.5(−4.5to1.4) 0.82(0.56to1.19) .30
Fluidleaking(notpus) 50/715(7.0) 60/687(8.7) −1.8(−4.7to0.9) 0.76(0.51to1.14) .18
Treatmentforcomplication
Surgicallyb 1/573(0.2) 2/575(0.3) −0.2(−0.8to0.4) 0.39(0.03to5.06) .47
Antibiotic 25/724(3.5) 27/689(3.9) −0.5(−2.5to1.5) 0.87(0.50to1.51) .61
aDidnotmeetthedefinitionofdeepsurgicalsiteinfectionfromtheUSCentersforDiseaseControlandPrevention.Someparticipantsexperienced
morethan1woundhealingcomplication.
bDatawerenotavailableforallparticipants.
Patientswithopenfracturesofthelowerlimbthatcouldnot tientswhowererandomizedwouldsubsequentlybeunable
beclosedprimarilyatthefirstsurgicalwounddebridement orunwillingtoparticipate.However,themajorityofpatients
wereexcludedfromthistrial.Thesepatientsareatthehighest (85%)agreedtoparticipate.
riskofsurgicalsiteinfectionandtheuseofnegativepressure Second,100patientsdidnotreceivetherandomized
woundtherapyhaspreviouslybeenreportedintheWoundMan- intervention.Asexpected,whentestingarelativelynew
agementofOpenLowerLimbFractures(WOLLF)trial.15The interventionsuchasincisionalnegativepressurewound
WOLLFtrialfoundnoevidencethatsurfacenegativepressure therapy,themajorityofthecrossoverswerefromtheinci-
woundtherapyreducedpatient-reporteddisabilityforthose sionalnegativepressurewoundtherapygrouptothestan-
withopenwoundsassociatedwithfracturesofthelowerlimb. dardwounddressinggroup(n=92).Theanalysisbythe
Thetrialreportedhereinaddressestheuseofadifferent treatmentreceivedconfirmedtheresultoftheprimary
typeofnegativepressurewoundtherapyplacedoveraclosed analysis(ie,therewasnosignificantdifferencebetweenthe
surgicalincisionforwoundsthathaveahighriskfordeep groupsofparticipants).
woundinfection.Attheinceptionofthistrial,therehadbeen Third,intermsofassessingtheprimaryoutcomeofinfec-
only1othertrial7comparingincisionalnegativepressure tion,theeventrateat30dayswaslowerthanreportedinthe
woundtherapyvsstandardwounddressingappliedtosurgi- literatureandlowerthananticipatedduringthetrialdevelop-
calwoundsinthecontextofmajortrauma.Thattrial7indi- ment.Thismayreflectrecentimprovementsinthecarepath-
catedthatincisionalnegativepressurewoundtherapyre- waysforpatientswithmajortrauma.18Oritmaysimplyre-
ducedtherateofdeepsurgicalsiteinfectionvsstandardwound flectchangesinthewaythatdatarelatingtodeepsurgicalsite
dressing.However,thepreviousstudywasconsiderably infectionarereported.Thesecondaryanalysisoftheprimary
smaller(n=249)thanthetrialreportedherein. outcomeofdeepsurgicalsiteinfectionat90days,asperthe
Asystematicreviewoftheliteratureconductedsincethe changeintheCDCcriteriaafterthetrialstarted,foundanevent
startofthistrialshows1additionalsmallrandomizedtrial16 ratemuchclosertothatpreviouslyreportedintheliterature
ofincisionalnegativepressurewoundtherapyvsstandard andusedinthesamplesizecalculationforthistrial.Therewas
wounddressingforsurgicalwoundsfollowingtrauma.Inthat alsonosignificantdifferencebetweentreatmentgroupsatthis
trial,66patientsundergoingsurgeryforfixationofanacetabu- timepoint.
larfracturewererandomizedtoincisionalnegativepressure However,thisestimateat90daysislessprecisethanthat
woundtherapyvsstandardgauzedressing.Therewasnoevi- at30daysduetohigherlevelsofmissingdata.Inmitigation
denceofastatisticallysignificantdifferenceintherateofdeep ofthelowerthanexpectedrateofinfectionattheprimaryend
surgicalsiteinfection;however,thenumberofdeepsurgical point,therateofthoselosttofollow-upat30dayswasless
siteinfectionswassmallwithonly2patients(6.1%)inthestan- than2%,whichwasconsiderablylowerthananticipated.
dardwounddressinggroupand5(15.2%)intheincisionalnega-
tivepressurewoundtherapygroup.Theonlyothertrial17re-
portedsincethecurrenttrialstarted,wasamechanisticstudy
Conclusions
involving20patientsinwhichultrasonographywasusedto
assesswoundseromaformationfollowingtheuseofinci- Amongpatientswhounderwentsurgeryformajortrauma–
sionalnegativepressurewoundtherapyinpatientsreceiving relatedlowerlimbfractures,useofincisionalnegativepres-
surgeryforspinalfractures. surewoundtherapy,comparedwithstandardwounddress-
ing,resultedinnosignificantdifferenceintherateofdeep
Limitations surgicalsiteinfection.Thefindingsdonotsupporttheuseof
Thisstudyhasseverallimitations.First,becauseoftheemer- incisionalnegativepressurewoundtherapyinthissetting,al-
gencynatureofthesurgery,itwasanticipatedthatsomepa- thoughtheeventrateat30dayswaslowerthanexpected.
jama.com (Reprinted) JAMA February11,2020 Volume323,Number6 525
©2020AmericanMedicalAssociation.Allrightsreserved.
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
Research OriginalInvestigation EffectofIncisionalNegativePressureWoundTherapyvsStandardWoundDressingonDeepSSI
ARTICLEINFORMATION PhD(BrightonandSussexUniversityHospitalsNHS 3.HerronJ,HutchinsonR,LeckyF,etal.The
AcceptedforPublication:January5,2020. Trust),HaroonMajeed,MBBS(UniversityHospitals impactofageonmajororthopaedictrauma.Bone
ofNorthMidlandsNHSTrust),DamianMcClelland, JointJ.2017;99-B(12):1677-1680.
C 20or 2r 1e ,c totio adn d:T ah si us pa prt li ec mle ew na ts lic sto inrr gec thte ed no on naJ uu tly ho2 r0, M TrB usB tS ),( SU hn ai rv ae drs Bit hy aH tno as gp ait r,a Mls Sof (NN eo wrt ch aM sti ld el uan pd os nN TyH nS
e
4 Co. mM pc lF ice arr ta ion nM seA n,S com uit nh teS rW ed,B inou thla es tH reJ, aS tmch ew na tr otz fHS.
collaborators. HospitalsNHSFoundationTrust),CarolineHing, pilonfractures.JOrthopTrauma.1992;6(2):195-200.
AuthorContributions:DrCostaandMsDutton PhD(StGeorgesUniversityHospitalsNHS
hadfullaccesstoallofthedatainthestudyand FoundationTrust),RajarshiBhattacharya,MBBS 5.YoungMJ,BarrackRL.Complicationsofinternal
takeresponsibilityfortheintegrityofthedataand (ImperialCollegeHealthcareNHSTrust),Usman fixationoftibialplateaufractures.OrthopRev.
theaccuracyofthedataanalysis. Butt,MBChB(SalfordRoyalNHSFoundationTrust), 1994;23(2):149-154.
Conceptanddesign:Costa,Achten,Bruce,Dutton, GeorgeCox,MD(UniversityHospitalSouthampton 6.GlassGE,MurphyGF,EsmaeiliA,etal.
Madan,Dritsaki,Parsons,Fernandez,Grant, NHSFoundationTrust),KhitishMohanty,MBBS Systematicreviewofmolecularmechanismof
Nanchahal. (CardiffandValeUniversityLHB),MateenArastu, actionofnegative-pressurewoundtherapy.BrJSurg.
Acquisition,analysis,orinterpretationofdata: MBBS(UniversityHospitalsCoventryand 2014;101(13):1627-1636.
Costa,Achten,Knight,Bruce,Dritsaki,Grant, WarwickshireNHSTrust),PaulHarwood,MBChB 7.StannardJP,VolgasDA,McGwinGIII,etal.
Nanchahal. (LeedsTeachingHospitalsNHSTrust),AlexSims, Incisionalnegativepressurewoundtherapyafter
Draftingofthemanuscript:Costa,Achten,Bruce, PhD(SouthTeesHospitalsNHSFoundationTrust), high-risklowerextremityfractures.JOrthopTrauma.
Dutton,Dritsaki,Fernandez,Grant. BrettRocos,MD(NorthBristolNHSTrust),Ian 2012;26(1):37-42.
Criticalrevisionofthemanuscriptforimportant Baxter,MBBS(SheffieldTeachingHospitalsNHS
intellectualcontent:Achten,Knight,Dutton, FoundationTrust),TanvirKhan,MBBS(University 8.AchtenJ,VadherK,BruceJ,etal.Standard
Madan,Dritsaki,Parsons,Nanchahal. ofNottingham),PaulGuyuer,MBBS(Plymouth woundmanagementversusnegative-pressure
Statisticalanalysis:Knight,Dutton. HospitalsNHSTrust),SiddhantKapoor,MBBS woundtherapyinthetreatmentofadultpatients
Obtainedfunding:Costa,Achten,Dutton,Madan, (UniversityHospitalsBirminghamNHSFoundation havingsurgicalincisionsformajortraumatothe
Parsons,Fernandez,Nanchahal. Trust),MichalisKaminaris,MBBS(StGeorges lowerlimb-atwo-armparallelgroupsuperiority
Administrative,technical,ormaterialsupport: UniversityHospitalsNHSFoundationTrust), randomisedcontrolledtrial:protocolforWound
Costa,Achten,Bruce,Dutton. EdwardMassa,MBBS(King’sCollegeHospitalNHS HealinginSurgeryforTrauma(WHIST).BMJOpen.
Supervision:Costa,Dutton,Madan,Grant. FoundationTrust),RichardUnsworth,MBBS 2018;8(6):e022115.
ConflictofInterestDisclosures:DrBruce (SalfordRoyalNHSFoundationTrust),Robert 9.KnightR,SpoorsLM,CostaML,DuttonSJ.
reportedreceivingpersonalfeesfromMedtronic. Jordan,MBChB(UniversityHospitalsCoventryand WoundHealingInSurgeryforTrauma(WHIST):
DrNanchahalreportedreceivingpersonalfeesand WarwickshireNHSTrust),TarekBoutefnouchet, statisticalanalysisplanforarandomisedcontrolled
nonfinancialsupportfromSmith&Nephewand MBChB(UniversityHospitalsCoventryand trialcomparingstandardwoundmanagementwith
Orthofix.Nootherdisclosureswerereported. WarwickshireNHSTrust),LauraBeddard,MBBS negativepressurewoundtherapy.Trials.2019;20
(PooleHospitalNHSFoundationTrust),and (1):186.
Funding/Support:Thisprojectwasfundedby GrahamLawton,MD(ImperialCollegeHealthcare
grantHTA14/199/14fromtheUKNationalInstitute NHSTrust).Collaboratorsalsoappearin 10.HoranTC,AndrusM,DudeckMA.CDC/NHSN
forHealthResearchHealthTechnologyAssessment Supplement5 surveillancedefinitionofhealthcare-associated
ProgrammeandwassupportedbytheNational infectionandcriteriaforspecifictypesofinfections
InstituteforHealthResearchOxfordBiomedical Disclaimer:Theviewsexpressedarethoseofthe intheacutecaresetting.AmJInfectControl.
ResearchCentre.SmithandNephewprovided authorsandnotnecessarilythoseoftheUK 2008;36(5):309-332.
incisionalnegativepressurewoundtherapy NationalHealthService,theNationalInstitutefor 11.SalénBA,SpangfortEV,NygrenAL,Nordemar
dressings(PICOsingleusenegativepressure HealthResearch,ortheDepartmentofHealth. R.TheDisabilityRatingIndex.JClinEpidemiol.
woundtherapysystem)torecruitingcenters. DataSharingStatement:SeeSupplement4. 1994;47(12):1423-1435.
RoleoftheFunder/Sponsor:Thesponsorshad AdditionalContributions:Wethankallthose 12.BrooksR.EuroQol:thecurrentstateofplay.
noroleinthedesignandconductofthestudy; involvedintheWHISTTrial,includingthepatients HealthPolicy.1996;37(1):53-72.
collection,management,analysis,and andtheresearchassociatesatalltheresearchsites 13.DraaijersLJ,TempelmanFR,BotmanYA,etal.
interpretationofthedata;preparation,review,or andinparticularLouiseSpoors(Universityof ThePatientandObserverScarAssessmentScale.
approvalofthemanuscript;anddecisiontosubmit Oxford),MartaCampolier,PhD(Universityof PlastReconstrSurg.2004;113(7):1960-1965.
themanuscriptforpublication. Oxford),andDamianHaywood(Universityof
( T HW C r ouaH ssmI ptS ) ib t,T r aSiT ld i )mr ,gi Da e ol anUC vSn io dcil v ol Ma e tb r t es ,o li M lt ir nya B gt H Co ,o Mhr ss B Bp: (iP Ct Ae a hilt n Bse tNr (r ReH H oeu S yUl al F, n loM Niu vB aen tC rd is oh a it ntB yi ao ln O m r Oex xa pf fn ro oear rsgd dee) )n ,mf fto oaer t rnt i hvth , e ee S , li pr u Jai z wn map in teu hn st e tMi hn J eo at sr n ai t nea el s arc lsf yo ,o sPo r isr hind oDpi fn u ( ca Ut lt in naio is iv cn a e aa r llan s diyd aty tao ,f 1 P c 24 h 0re a. 0v rB a 8ao cl ;e 1tu 3enh 6rca ie (ss 3tos i )ci :fr 3sa c 8ih nD 0r, to -L h 3na e 8icn g 7t p .eé a nr ii en-M rw ai ln i pte h ot pnM ueu l, aA r to it ot pa nal .tN h P, i ace int .al.
OrthopaedicHospitalNHSTrust),JavedSalim, andKaranVadher,MSc(UniversityofOxford),for 15.CostaML,AchtenJ,BruceJ,etal.Effectof
MBBS(HullUniversityTeachingHospitalsNHS helpwiththestatisticalanalysis.LouiseSpoors, negativepressurewoundtherapyvsstandard
Trust),HemantSharma,MS(HullUniversity MartaCampolier,DamianHaywood,andKaran woundmanagementon12-monthdisabilityamong
TeachingHospitalsNHSTrust),WilliamEardley,MD VadherwerepartiallyfundedbytheNational adultswithsevereopenfractureofthelowerlimb.
(SouthTeesHospitalsNHSFoundationTrust),Peter InstituteforHealthResearchaward.Theothers JAMA.2018;319(22):2280-2288.
Giannoudis,MD(UniversityofLeeds),Jitendra listeddidnotreceivefundingfortheir 16.WebsterJ,ScuffhamP,SherriffKL,etal.
Mangwani,MBBS(UniversityHospitalsofLeicester contributions. Negativepressurewoundtherapyforskingrafts
NHSTrust),AndrewRiddick,MBBCh(NorthBristol andsurgicalwoundshealingbyprimaryintention.
NHSTrust),PaulHarnett,MBChB(King’sCollege REFERENCES CochraneDatabaseSystRev.2012;(4):CD009261.
HospitalNHSFoundationTrust),EdwardMills, 1.LozanoR,NaghaviM,ForemanK,etal.Global 17.CristBD,OladejiLO,KhazzamM,etal.Roleof
MBBS(SheffieldTeachingHospitalsNHS andregionalmortalityfrom235causesofdeathfor acutenegativepressurewoundtherapyover
FoundationTrust),MikeReed,PhD(Northumbria 20agegroupsin1990and2010[published primarilyclosedsurgicalincisionsinacetabular
HealthcareNHSFoundationTrust),BenOllivere, correctionappearsinLancet.2013;381(9867):628]. fractureORIF.Injury.2017;48(7):1518-1521.
MD(UniversityofNottingham),XavierGriffin,PhD Lancet.2012;380(9859):2095-2128.
( (U Pln yi mve or us tit hy Ho of sO px if to alr sd N), HM Sa Trk ruB sr ti )n ,s Rd ae vn ic, hM aB ndB rS
an
2 an. dN ia nt ii to ian la mlA anu ad git eO mf efi nc te .. hM tta pjo s:r //t wra wum w.a n: ia cs es .oe rs gs .m uke /nt 1 th8 e. sM yso tr ea mn —CG m, aL je oc rk ty raF u, mBo au pa am tiera ntO s, ae nt dal t. hC eh iranging
Karthikeyan,MBBS(UniversityHospitals guidance/ng39.AccessedJanuary10,2020. outcomesintheNHS(England)2008-17.
BirminghamNHSFoundationTrust),PeterBates, EClinicalMedicine.2018;2-3:13-21.
MSBS(BartsHealthNHSTrust),BenedictRogers,
526 JAMA February11,2020 Volume323,Number6 (Reprinted) jama.com
©2020AmericanMedicalAssociation.Allrightsreserved.
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
